Article Details

Diasorin heads to the US with $1.8bn Luminex deal

Retrieved on: 2021-04-12 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

Diasorin heads to the US with $1.8bn Luminex deal. View article details on hiswai:

Excerpt

Yesterday's debt-fuelled purchase of Luminex by Diasorin is, at $1.8bn, tied with Roche's takeout of Genmark Diagnostics as the biggest acquisition of ...

Article found on: www.evaluate.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up